ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BEAT vs NEPH // RETURN ON INVESTED CAPITAL (ROIC)

Heartbeam Inc. (NASDAQ) VS. Nephros Inc. (NASDAQ) • 15-METRIC TALLY: BEAT 1 — NEPH 3
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: NEPH
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BEAT VS. NEPH) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BEAT NEPH SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 61.90% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE -35.00% 18.90% -53.90 NEPH /roic <GO>
EV/EBITDA & P/E Valuation — 26.3x — TIE /valuation <GO>
Free Cash Flow Yield — 4.50% — TIE /fcf-yield <GO>
Operating Margin — 6.10% — TIE /operating-margins <GO>
Net Profit Margin — 6.40% — TIE /net-margins <GO>
Revenue Growth (YoY) — 32.70% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 8/9 -6.00 NEPH /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 62.8 38.0 +24.80 BEAT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 25.0x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $31.0M $34.5M -$3.5M NEPH /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BEAT REV NEPH REV BEAT GROSS % NEPH GROSS % BEAT FCF NEPH FCF
FY 2025 $0 $18.8M — 61.9% -$14.6M $1.6M
FY 2024 $0 $14.2M — 61.6% -$14.7M -$547.0K
FY 2023 $0 $14.2M — — -$12.1M $827.0K
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BEAT // BETA —
NEPH // BETA —